Feline Chronic Gingivostomatitis: Welfare Management

Key Welfare Considerations

• FCGS involves severe, painful inflammation of the gingiva and oral mucosa beyond the gum line.
• The condition causes profound oral pain welfare impacts — affected cats show pain behaviours, dysphagia, and weight loss.
• The aetiology involves immune dysregulation with viral triggers including FCV and FHV-1.
• Medical management with antibiotics, steroids, and immunosuppressants provides temporary welfare relief at best.
• Full mouth extraction (FME) is the definitive welfare treatment — 60-80% of cats improve dramatically.
• Partial responses to FME may require additional staged extractions until oral inflammation welfare resolves.
• Pre-surgical pain management with opioids and NSAIDs is welfare-mandatory for FCGS intervention.
• Liquid diets and appetite stimulants support welfare nutrition during oral disease management.
• Cats recover feeding function remarkably well after FME — quality of life welfare typically improves substantially.
• Immunomodulatory treatments including interferons and lactoferrin may provide adjunctive welfare benefit.
• Cyclosporine provides welfare benefit in some FCGS cases by modulating immune hyperactivation.
• Pain scoring using feline grimace scale guides analgesic intensity in welfare management.
• Dental radiography before extraction ensures complete root removal — retained roots perpetuate welfare inflammation.
• Owner counselling about FME outcome expectations supports welfare-informed treatment decisions.
• Annual oral examination should identify early FCGS signs before severe welfare deterioration occurs.